MARPE-Associated Changes in Sleep and Airway

Recruiting now · Not applicable

Conditions studied: Rapid Maxillary Expansion

In brief

At the beginning of MARPE treatment (T1) and at the end of the 3-month consolidation phase (T2), patients will complete the teen-STOP-BANG questionnaire and the Pittsburgh Sleep Quality Index (PSQI) to assess the potential benefit of MARPE in reducing the risk of obstructive sleep apnea syndrome (OSAS). Additionally, changes in the upper airway will be evaluated using CBCT images obtained at T1 and T2.

Key facts

Study ID

NCT07031349

Run by

Konya Necmettin Erbakan Üniversitesi

People needed

40

Starts

2025-05-30

Expected to finish

2025-09-05

Last updated by the study team

2025-06-26

Who can join

Age: 15 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Class I malocclusion Maxillary transverse deficiency Age between 15 and 18 years No systemic disease, cleft lip and palate, or speech disorders No history of prior orthodontic treatment Voluntary agreement to participate in the study Good oral hygiene ANB angle between 2° and 5°

You may not qualify if…

• Presence of systemic diseases Smoking Poor oral hygiene Lack of cooperation Mental retardation Obesity or nutritional disorders Macroglossia or mandibular retrognathia

Where it is running

• Necmettin Erbakan University — Konya, Meram, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.